These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 17596405

  • 1. Comment on: Kretowski et al. (2007) Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis: Diabetes 56:863-871.
    van Beers EJ, Meuwese MC.
    Diabetes; 2007 Jul; 56(7):e5; author reply e6. PubMed ID: 17596405
    [No Abstract] [Full Text] [Related]

  • 2. Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis.
    Kretowski A, McFann K, Hokanson JE, Maahs D, Kinney G, Snell-Bergeon JK, Wadwa RP, Eckel RH, Ogden L, Garg S, Li J, Cheng S, Erlich HA, Rewers M.
    Diabetes; 2007 Mar; 56(3):863-71. PubMed ID: 17327458
    [Abstract] [Full Text] [Related]

  • 3. The renin-angiotensin-aldosterone system: approaches to guide angiotensin-converting enzyme inhibition in patients with coronary artery disease.
    Brugts JJ, den Uil CA, Danser AH, Boersma E.
    Cardiology; 2009 Mar; 112(4):303-12. PubMed ID: 18832826
    [Abstract] [Full Text] [Related]

  • 4. Genetic determinants of cardiovascular disease: the renin-angiotensin-aldosterone system, paraoxonases, endothelin-1, nitric oxide synthase and adrenergic receptors.
    Gluba A, Banach M, Mikhailidis DP, Rysz J.
    In Vivo; 2009 Mar; 23(5):797-812. PubMed ID: 19779116
    [Abstract] [Full Text] [Related]

  • 5. Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes.
    Maahs DM, Ogden LG, Kretowski A, Snell-Bergeon JK, Kinney GL, Berl T, Rewers M.
    Diabetes; 2007 Nov; 56(11):2774-9. PubMed ID: 17660266
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Polymorphisms in the genes of the renin system and progression of renal disease: a critical review.
    Zoccali C, Testa A, Spoto B.
    Adv Nephrol Necker Hosp; 2001 Nov; 31():105-17. PubMed ID: 11692453
    [No Abstract] [Full Text] [Related]

  • 9. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men.
    Adamzik M, Frey UH, Bitzer K, Jakob H, Baba HA, Schmieder RE, Schneider MP, Heusch G, Peters J, Siffert W.
    Basic Res Cardiol; 2008 Nov; 103(6):598-610. PubMed ID: 18846354
    [Abstract] [Full Text] [Related]

  • 10. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
    Volkan-Salanci B, Dagdelen S, Alikasifoglu M, Erbas T, Hayran M, Erbas B.
    J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):41-50. PubMed ID: 19286758
    [Abstract] [Full Text] [Related]

  • 11. Comments to: Tarnow L, Kjeld T, Knudsen E et al. (2000) lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients. Diabetologia 43: 794-799.
    Soltész G, Rózsai B.
    Diabetologia; 2001 Apr; 44(4):520. PubMed ID: 11357488
    [No Abstract] [Full Text] [Related]

  • 12. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
    Akman B, Tarhan C, Arat Z, Sezer S, Ozdemir FN.
    Ren Fail; 2009 Apr; 31(3):196-200. PubMed ID: 19288324
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort study.
    Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY.
    J Intern Med; 2008 Apr; 263(4):376-85. PubMed ID: 18069999
    [Abstract] [Full Text] [Related]

  • 18. Survival in type 2 diabetic patients in dialysis and the number of risk alleles in polymorphisms of the renin-angiotensin system genes.
    Padró-Miquel A, Alía-Ramos P, González-Alvarez MT, Navarro-Moreno MA.
    Clin Biochem; 2009 Jan; 42(1-2):5-11. PubMed ID: 19014923
    [Abstract] [Full Text] [Related]

  • 19. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
    Bozkurt O, de Boer A, Grobbee DE, Kroon AA, Schiffers P, de Leeuw P, Klungel OH.
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.